Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03416725
Other study ID # MERI
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 12, 2018
Last updated January 24, 2018
Start date March 1, 2018
Est. completion date March 1, 2020

Study information

Verified date January 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Tympanoplasty is the surgical operation performed for the reconstruction of the eardrum and/or the ossicles. Tympanoplasty is classified into five different types, originally described by Horst Ludwig Wullstein. 1,2 Type 1 involves repair of the tympanic membrane alone, when the middle ear is normal. A type 1 tympanoplasty is synonymous to myringoplasty, Type 2 involves repair of the tympanic membrane and middle ear in spite of slight defects in the middle ear ossicles, Type 3 when mallus and incus are absent graft place directly on stapes head., Type 4 describes a repair when the stapes foot plate is movable, but the crura are missing. The resulting middle ear will only consist of the Eustachian tube and hypotympanum, Type 5 is a repair involving a fixed stapes footplate.

There are various prognostic factors reported in the literature that may influence the surgical success of tympanoplasty.


Description:

Some studies report significance for some of these factors whereas others report the contrary. The reported incidence of surgical success of tympanoplasty ranges from 60% to 99% in adults Belluci described four separate stages for prognosis of tympanoplasty 4 according to otorrhea

. Austin proposed a prognostic stratification according to disease categories, stage categories, and disease descriptors.

Black introduced the surgical, prosthetic, infection, tissues, and eustachian tube system (SPITE), and more recently Kartush developed middle ear risk index (MERI).

Smoking is added as a middle ear risk. Furthermore, cholesteatoma and granulation tissue or effusion risk value has been increased in MERI 2001.

Prognostic factors such as age, sex, presence of systemic diseases, location and size of perforation, duration of dry period, presence of myringosclerosis, presence of septal and conchal pathology, operation type, and status of the opposite ear and middle ear risk index were investigated. 9


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 70
Est. completion date March 1, 2020
Est. primary completion date March 1, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- patients of the age group 18-60 years with Chronic suppurative otitis media (CSOM) planned for tympanoplasty.

Exclusion Criteria:

- Patients with otomycosis, septic foci such as sinusitis which can influence the outcome of tympanoplasty were excluded from the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Otoscope
Otoscopic examination will be done to find the presence or absence of perforation, granulation tissue and cholesteatoma.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Becvarovski Z, Kartush JM. Smoking and tympanoplasty: implications for prognosis and the Middle Ear Risk Index (MERI). Laryngoscope. 2001 Oct;111(10):1806-11. — View Citation

Kartush JM. Ossicular chain reconstruction. Capitulum to malleus. Otolaryngol Clin North Am. 1994 Aug;27(4):689-715. Review. — View Citation

WULLSTEIN H. Theory and practice of tympanoplasty. Laryngoscope. 1956 Aug;66(8):1076-93. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of prognostic factors in tympanoplasty to predict the outcome of the surgical management whenever done. Prognostic factors such as age, sex, presence of systemic diseases, location and size of perforation, duration of dry period, presence of myringosclerosis, presence of septal and conchal pathology and status of the opposite ear and middle ear risk index will be investigated. One year
Primary Evaluation of middle ear risk index in tympanoplasty Each risk parameter will take a numerical value; Ear discharge: 0-3, Perforation: 0-2, Cholesteotoma: 0-2, Ossicular chain status: 0-4, Middle ear granulation and history of previous surgery: 0-2. Now newly, smoking is also included as a risk parameter. The MERI will be evaluated. The patients will be categorized into those with mild (0-3), moderate(4-6) and severe(=7) MERI One year
See also
  Status Clinical Trial Phase
Recruiting NCT04635228 - Biodesign® Otologic Repair Graft
Active, not recruiting NCT00222417 - Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease Phase 2/Phase 3
Recruiting NCT05086718 - Composite Cartilage Perichondrium Graft for Air Bone Gap Closure in Chronic Suppurative Otitis Media (CSOM) Without Posterior Meatal Flap N/A
Withdrawn NCT03904316 - Use of Biodesign® Otologic Graft in Tympanoplasty Phase 4
Completed NCT02307916 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Terminated NCT01766856 - Eustachian Tube Function and Myringoplasty/Tympanoplasty N/A
Recruiting NCT06260618 - Effect of Chitodex Gel in Tympanoplasty Surgery N/A
Recruiting NCT04960384 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Recruiting NCT03837665 - Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation Phase 1/Phase 2
Not yet recruiting NCT06257602 - Microscopic Versus Endoscopic Tympanoplasty
Completed NCT02550314 - A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18 Phase 3
Not yet recruiting NCT00310349 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease Phase 3
Not yet recruiting NCT04428463 - Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia N/A
Completed NCT00714064 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers Phase 3
Completed NCT05605262 - Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Phase 2/Phase 3
Completed NCT02296944 - Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child N/A
Recruiting NCT05849844 - Tympanoseal Clinical Study N/A
Not yet recruiting NCT04687995 - Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty N/A
Completed NCT02120651 - Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty Phase 3
Withdrawn NCT03028272 - Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty N/A